{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:50:16Z","timestamp":1759063816760},"reference-count":29,"publisher":"Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Infect Dis"],"published-print":{"date-parts":[[2016]]},"DOI":"10.7883\/yoken.jjid.2015.359","type":"journal-article","created":{"date-parts":[[2015,11,12]],"date-time":"2015-11-12T22:12:02Z","timestamp":1447366322000},"page":"306-313","source":"Crossref","is-referenced-by-count":2,"title":["Possible Involvement of Multidrug-Resistant Hepatitis B Virus sW172* Truncation Variant in the ER Stress Signaling Pathway during Hepatocarcinogenesis"],"prefix":"10.7883","volume":"69","author":[{"given":"Jiajia","family":"Zheng","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Peking University Third Hospital"},{"name":"Centers for the Infectious Disease & the Department of Microbiology, Peking University Health Science Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzhen","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Peking University International Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengmin","family":"Lu","sequence":"additional","affiliation":[{"name":"Centers for the Infectious Disease & the Department of Microbiology, Peking University Health Science Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4631","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Lee WM. Hepatitis B virus infection. N Engl J Med. 1997;337:1733-45.","DOI":"10.1056\/NEJM199712113372406"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Durantel D, Brunelle MN, Gros E, et al. Resistance of human hepatitis B virus to reverse transcriptase inhibitors: from genotypic to phenotypic testing. J Clin Virol. 2005; 34 Suppl 1:S34-S43.","DOI":"10.1016\/S1386-6532(05)80008-3"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Zoulim F, Locarnini S. Hepatitis B virus resistance to nucleos(t)ide analogues. Gastroenterology. 2009;137:1593-608.","DOI":"10.1053\/j.gastro.2009.08.063"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Yeh CT. Development of HBV S gene mutants in chronic hepatitis B patients receiving nucleotide\/nucleoside analogue therapy. Antivir Ther. 2010;15:471-5.","DOI":"10.3851\/IMP1552"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Lee YS, Suh DJ, Lim YS, et al. Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy. Hepatology. 2006;43:1385-91.","DOI":"10.1002\/hep.21189"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Yeon JE, Yoo W, Hong SP, et al. Resistance to adefovir dipivoxil in lamivudine resistant chronic hepatitis B patients treated with adefovir dipivoxil. Gut. 2006;55:1488-95.","DOI":"10.1136\/gut.2005.077099"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Qi X, Xiong S, Yang H, et al. In vitro susceptibility of adefovir-associated hepatitis B virus polymerase mutations to other antiviral agents. Antivir Ther. 2007;12:355-62.","DOI":"10.1177\/135965350701200309"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Villet S, Pichoud C, Billioud G, et al. Impact of hepatitis B virus rtA181V\/T mutants on hepatitis B treatment failure. J Hepatol. 2008;48:747-55.","DOI":"10.1016\/j.jhep.2008.01.027"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Neumann-Fraune M, Beggel B, Pfister H, et al. High frequency of complex mutational patterns in lamivudine resistant hepatitis B virus isolates. J Med Virol. 2013;85:775-9.","DOI":"10.1002\/jmv.23530"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Warner N, Locarnini S. The antiviral drug selected hepatitis B virus rtA181T\/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound. Hepatology. 2008;48:88-98.","DOI":"10.1002\/hep.22295"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Lai MW, Yeh CT. The oncogenic potential of hepatitis B virus rtA181T\/ surface truncation mutant. Antivir Ther. 2008;13:875-9.","DOI":"10.1177\/135965350801300701"},{"key":"12","unstructured":"12. Warner N, Locarnini S. Can antiviral therapy for chronic hepatitis B enhance the progression to hepatocellular carcinoma? Antivir Ther. 2009;14:139-42."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Liang T, Chen EQ, Tang H. Hepatitis B virus gene mutations and hepatocarcinogenesis. Asian Pac J Cancer Prev. 2013;14:4509-13.","DOI":"10.7314\/APJCP.2013.14.8.4509"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Lai MW, Huang SF, Hsu CW, et al. Identification of nonsense mutations in hepatitis B virus S gene in patients with hepatocellular carcinoma developed after lamivudine therapy. Antivir Ther. 2009;14:249-61.","DOI":"10.1177\/135965350901400216"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Patil C, Walter P. Intracellular signaling from the endoplasmic reticulum to the nucleus: the unfolded protein response in yeast and mammals. Curr Opin Cell Biol. 2001;13:349-55.","DOI":"10.1016\/S0955-0674(00)00219-2"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Kim I, Xu W, Reed JC. Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities. Nat Rev Drug Discov. 2008;7:1013-30.","DOI":"10.1038\/nrd2755"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Wang HC, Huang W, Lai MD, et al. Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis. Cancer Sci. 2006;97:683-8.","DOI":"10.1111\/j.1349-7006.2006.00235.x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Shuda M, Kondoh N, Imazeki N, et al. Activation of the ATF6, XBP1 and grp78 genes in human hepatocellular carcinoma: a possible involvement of the ER stress pathway in hepatocarcinogenesis. J Hepatol. 2003;38:605-14.","DOI":"10.1016\/S0168-8278(03)00029-1"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Fernandez PM, Tabbara SO, Jacobs LK, et al. Overexpression of the glucose-regulated stress gene GRP78 in malignant but not benign human breast lesions. Breast Cancer Res Treat. 2000;59:15-26.","DOI":"10.1023\/A:1006332011207"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Ahn SH, Park YK, Park ES, et al. The impact of the hepatitis B virus polymerase rtA181T mutation on replication and drug resistance is potentially affected by overlapping changes in surface gene. J Virol. 2014;88:6805-18.","DOI":"10.1128\/JVI.00635-14"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Eble BE, MacRae DR, Lingappa VR, et al. Multiple topogenic sequences determine the transmembrane orientation of the hepatitis B surface antigen. Mol Cell Biol. 1987;7:3591-601.","DOI":"10.1128\/MCB.7.10.3591"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Bruss V, Ganem D. Mutational analysis of hepatitis B surface antigen particle assembly and secretion. J Virol. 1991;65:3813-20.","DOI":"10.1128\/JVI.65.7.3813-3820.1991"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Seeger C, Mason WS. Hepatitis B virus biology. Microbiol Mol Biol Rev. 2000;64:51-68.","DOI":"10.1128\/MMBR.64.1.51-68.2000"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Dai J, Chen EQ, Bai L, et al. Biological characteristics of the rtA181T\/sW172* mutant strain of Hepatitis B virus in animal model. Virol J. 2012;9:280.","DOI":"10.1186\/1743-422X-9-280"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Malhotra JD, Kaufman RJ. The endoplasmic reticulum and the unfolded protein response. Semin Cell Dev Biol. 2007;18:716-31.","DOI":"10.1016\/j.semcdb.2007.09.003"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol. 2007;8:519-29.","DOI":"10.1038\/nrm2199"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Hsieh YH, Su IJ, Wang HC, et al. Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage. Carcinogenesis. 2004;25:2023-32.","DOI":"10.1093\/carcin\/bgh207"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Yang JC, Teng CF, Wu HC, et al. Enhanced expression of vascular endothelial growth factor-A in ground glass hepatocytes and its implication in hepatitis B virus hepatocarcinogenesis. Hepatology. 2009;49:1962-71.","DOI":"10.1002\/hep.22889"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Yeh CT, Chen T, Hsu CW, et al. Emergence of the rtA181T\/sW172* mutant increased the risk of hepatoma occurrence in patients with lamivudine-resistant chronic hepatitis B. BMC Cancer. 2011;11:398.","DOI":"10.1186\/1471-2407-11-398"}],"container-title":["Japanese Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/69\/4\/69_JJID.2015.359\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T00:48:58Z","timestamp":1653526138000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/69\/4\/69_JJID.2015.359\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.7883\/yoken.jjid.2015.359","relation":{},"ISSN":["1344-6304","1884-2836"],"issn-type":[{"value":"1344-6304","type":"print"},{"value":"1884-2836","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}